Accelerated Discovery of Functionally Relevant Antibodies Leveraging Broadened Epitopic Diversity and Single B-Cell Screening
ABVERIS WEBINAR 4/2021
DiversimAb Platform Benefits with Broadened Epitopic Diversity for Antibody Discovery
DiversimAb Technical Handout
Abveris/Berkeley Lights Joint Application Note
Joint application note with Berkeley Lights on advanced assays using Beacon Platform
Targeting GPCRs via High-Resolution, Function-Forward Single B Cell Antibody Discovery
Discovery on Target 2021
Function vs Force: Accelerated Identification of Relevant Antibody Candidates in the Modern Discovery Landscape
PEGS Boston 2020
Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
Abveris/Berkeley Lights Joint Webinar 4/2020
Accelerated High-Throughput Antibody Discovery with High-throughput & High-Content Screening Technologies
abveris/carterra joint webinar 06/2021
De-risking Antibody Discovery: Tips for Success from Industry Experience
Abveris Webinar 9/2020
Abveris Ultra-rapid, High Resolution Single B Cell Screening Workflow by Beacon
B Cell Screening Poster
Targeting Cell Surface Receptors in Single B Cell Screening Antibody Discovery Workflow
Festival of Biologics Europe 2020
Accelerated, Function-Forward Therapeutic Antibody Discovery Targeting an Intractable Cell Surface Receptor using Hyperimmune & Humanized Mice
Beacon-based therapeutic antibody discovery case study
Accelerated Antibody Discovery Targeting the SARS-CoV-2Spike Protein for COVID-19 Therapeutic Potential
Open-Access Antibody Sequences
Accelerated Therapeutic Antibody Discovery Targeting a Cell Surface Receptor using a Beacon-Based Single B Cell Workflow
BEacon-based therapeutic antibody discovery case study
Rapid mAb Discovery against Cell Surface Receptor Based on B cell Screening on Adherent Cell Lines in 29 Days
Beacon-based therapeutic antibody discovery case study
Human mAb Discovery based on Alloy Humanized Mice and a Function-Forward Hybridoma Workflow
Function-Forward Hybridoma-based Human Antibody Discovery Case Study
Hybridoma-based Anti-idiotypic mAb Discovery against a Bispecific Therapeutics for PK/ADA Assays Development
Anti-Idiotypic Antibody Discovery Case Study
Ultrafast Single B Cell-based Anti-idiotypic mAb Discovery against an mAb Therapeutics
anti-idiotypic antibody discovery case study
Identifying Specific mAb Binders to a CAR, Enabling Drug Quantification in Patient Serum Sample
anti-idiotypic antibody discovery case study
Advanced Antibody Discovery Workflow to Capture Maximum Repertoire Diversity
Antibody Engineering & Therapeutics San Diego 2021 Poster
Anti-Idiotypic mAb Discovery Part I: Screening Strategy for Anti-Idiotypic mAb (Anti-Id) as Critical PK/ADA Assay Reagents
Abveris Webinar 2/24/2022
Anti-Idiotypic mAb Discovery Part II: Anti-Ids against engineered biologics and CAR-Ts
Abveris Webinar 3/10/2022
Function-Forward, Rapid Mab Discovery Against an Intractable Cell Surface Receptor Using DiversimAb and Humanized Mice
Abveris Webinar 3/24/2022
Accelerated Discovery of Functionally Relevant Ab Leveraging Broadened Epitopic Diversity & Single B Cell Screening
Abveris Webinar 4/7/22
Lessons Learned from 2+ Years of Discovering Functional Antibodies on the Beacon
Abveris Webinar 4/21/2022
In Vivo VHH/Nanobody Discovery with a Rapid Beacon-Based Single B Cell Workflow
Abveris Webinar 5/12/2022
An In Vivo Antibody Discovery Platform Designed for Challenging Therapeutic Targets
Abveris Webinar 5/26/22
